We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Updates Preauthorization Guidelines, Clarifying Common Errors
EMA Updates Preauthorization Guidelines, Clarifying Common Errors
August 5, 2013
Drugmakers must submit a full pediatric investigation plan (PIP) decision when seeking marketing authorization and not just an opinion, a common flub the European Medicines Agency (EMA) notes in a guideline update.